Filing metadata

Accession number
0001415889-22-002834
Form type
Form 3
Filer
Sigilon Therapeutics, Inc.
CIK
CIK 1821323
Filed
Mar 10, 2022
Reporting period
Mar 07, 2022
Description
Initial ownership

Explore SEC Filings Hub